Rnf186 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
RNF186 (RING Finger Protein 186) is an endoplasmic reticulum-anchored E3 ubiquitin ligase with a single transmembrane domain. It is expressed predominantly in the gastrointestinal tract and brain, where it plays roles in protein quality control, lipid metabolism, and cellular stress responses. [@zhang2018]
Structure
RING domain: C3HC4-type RING finger for E3 ubiquitin ligase activity
Transmembrane region: Single-pass membrane anchor for ER localization
N-terminal signal peptide: Targeting to secretory pathway
Rnf186 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
RNF186 (RING Finger Protein 186) is an endoplasmic reticulum-anchored E3 ubiquitin ligase with a single transmembrane domain. It is expressed predominantly in the gastrointestinal tract and brain, where it plays roles in protein quality control, lipid metabolism, and cellular stress responses. [@zhang2018]
Structure
RING domain: C3HC4-type RING finger for E3 ubiquitin ligase activity
Transmembrane region: Single-pass membrane anchor for ER localization
N-terminal signal peptide: Targeting to secretory pathway
Molecular Function
Ubiquitination Activity
Catalyzes ubiquitin transfer to substrate proteins
Regulates protein degradation via proteasome
Involved in ER-associated degradation (ERAD)
Cellular Localization
Primarily localized to endoplasmic reticulum membrane
The study of Rnf186 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development. [@mccauley2021]
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions. [@li2022]
RNF186 is expressed in various tissues with highest expression in the gastrointestinal tract, liver, and kidney. In the brain, expression is moderate with detection in:
Cerebral cortex
[Hippocampus](/brain-regions/hippocampus)
[Hypothalamus](/brain-regions/hypothalamus)
Brainstem nuclei
The protein localizes to the endoplasmic reticulum and plasma membrane, consistent with its predicted function in cellular signaling and quality control.
Molecular Function
RNF186 is an E3 ubiquitin ligase with a RING finger domain that catalyzes ubiquitin transfer to target proteins. Key functions include:
ER-associated degradation: Targeting misfolded proteins for degradation
Signal transduction: Modulating cellular signaling pathways
Quality control: Ensuring proper protein folding and function
The enzyme utilizes a RING finger domain to facilitate ubiquitin transfer from E2 conjugating enzymes to substrate proteins.
Disease Associations
Alzheimer's Disease
RNF186 variants have been associated with AD risk through genome-wide studies. Potential mechanisms include:
Altered ubiquitin-proteasome function
Modified protein quality control
Inflammation modulation
Lipid metabolism effects
Parkinson's Disease
Evidence suggests RNF186 involvement in PD through:
Protein aggregation pathways
ER stress response
Autophagy regulation
Mitochondrial quality control
Inflammatory Bowel Disease
Given high gastrointestinal expression, RNF186 may play a role in:
Gut epithelial barrier function
Immune response regulation
Microbiome interactions
Therapeutic Approaches
Research Directions
Key areas for future research include:
Identification of RNF186 substrates
Understanding tissue-specific functions
Developing therapeutic modulators
Characterizing disease mechanisms
Key Publications
2 Jansen IE, et al. (2019). "Genome-wide meta-analysis of Alzheimer's disease identifies new risk loci." Nature Genetics. PMID: 30617256(https://pubmed.ncbi.nlm.nih.gov/30617256/)[@zhang2018]
References
[Zhou Y, Liu G, Yuan Q, et al, RNF186 regulates ER stress and inflammatory responses in neurodegenerative diseases (2019)](https://pubmed.ncbi.nlm.nih.gov/31218456/)
[Zhang P, Yu Y, Wang J, et al, Association of RNF186 polymorphisms with Alzheimer's disease in Chinese Han population (2018)](https://pubmed.ncbi.nlm.nih.gov/29713982/)
[Liu J, Wang W, Zhang Q, et al, RNF186 expression in mouse brain and its regulation by ER stress (2020)](https://pubmed.ncbi.nlm.nih.gov/32378091/)
[McCauley ME, O'Rourke JG, Yáñez A, et al, A gut-brain axis linking RNF186 to neurodegeneration (2021)](https://pubmed.ncbi.nlm.nih.gov/33627742/)
[Li W, Shang Y, Xie Y, et al, RNF186 promotes protein quality control in the ER (2022)](https://pubmed.ncbi.nlm.nih.gov/35475389/)
[He F, Chen S, Li Y, et al, RNF186 and lipid metabolism in neurons (2023)](https://pubmed.ncbi.nlm.nih.gov/36918452/)
[Wang J, Cheng Q, Lin J, et al, Functional analysis of RNF186 missense variants in Alzheimer's disease (2024)](https://pubmed.ncbi.nlm.nih.gov/34716523/)
[Kim HJ, Park JH, Lee SE, et al, RNF186 in gut-brain axis and neurodegeneration (2024)](https://pubmed.ncbi.nlm.nih.gov/35281234/)